5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid

Star0

DB07945ExperimentalSmall molecule

5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid: Overview.

Formula / weight: C₂₂H₂₂N₂O₃ · 362.4217 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL516023PubChem9863791

Structure

InChIKeyGKBQRPKZHUFGOB-UHFFFAOYSA-NSMILESNC(=O)C1=CC=CC(CN2C3=C(CCCCC3)C3=CC=CC(C(O)=O)=C23)=C1

What you can answer from here — as of April 02, 2025

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of 5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account